Allianz Asset Management
BIVV

Allianz Asset Management’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Allianz Asset Management’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-411,187
Closed -$22.2M – 2815
2017
Q4 		$22.2M Buy
411,187
+103,419
+34% +$5.66M 0.02% 930
2017
Q3 		$17.6M Sell
307,768
-5,946
-2% -$348K 0.02% 1042
2017
Q2 		$18.9M Sell
313,714
-6,362
-2% -$362K 0.02% 1000
2017
Q1 		$17.4M Buy
+320,076
New +$15.8M 0.02% 1073

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Allianz Asset Management's BIVV Position: Q1 2018 in Review

Allianz Asset Management sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 411,187 shares — an estimated $22.2M sold.

Allianz Asset Management first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $22.2M in Q4 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • Allianz Asset Management reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Allianz Asset Management sold 411,187 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $22.2M.
  • Allianz Asset Management first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
  • Allianz Asset Management's Bioverativ Inc. Common Stock position peaked at $22.2M in Q4 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Allianz Asset Management's 13F filing for Q1 2018, filed 14 May 2018.